Promising drug by UAlberta researchers could save millions of lives.
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Heart specialist Gavin Oudit and his research team discovered a molecule—angiotensin converting enzyme 2 (ACE2)—that works to restore balance to the pathways responsible for chronic and acute heart failure, including in patients with advanced heart failure who underwent heart transplants.
In conducting their research, Oudit and his team used genetic mapping technology to discover to an extent not seen before how the renin-angiotensin system (RAS)—which regulates the body’s sodium balance, fluid volume and blood pressure—is at play in both acute and chronic heart failure.
It led to the creation of recombinant human ACE2, a new drug that was manufactured by Apeiron Biologics in collaboration with Oudit. It was bought by GlaxoSmithKline, which recently successfully completed phase II clinical trials that tested for the safety and efficacy of the drug on hundreds of patients. The new drug is expected to be on the market in the next three to five years.
Oudit added that using mapping technology has also made it possible to individualize the dose a patient needs, allowing for a truly personalized treatment plan for heart failure patients in the future. The study also broke ground by showing how ACE2 can be used in heart transplant patients with heart failure.
About six million Canadians will develop heart failure, a common condition that most often happens after the heart has been damaged or weakened by heart attack or stroke. According to the Canadian Heart and Stroke Foundation, the two most common causes of heart failure are heart attacks and high blood pressure. When someone has heart failure, the heart either can’t accept the inflow of blood or pump it out, or both.
“This research is a terrific example of how the university works together synergistically to develop world-class research and translate that into medicines that impact patient outcomes,” added Oudit.
Learn more: New hope for treating heart failure
Receive an email update when we add a new ARTIFICIAL SYNAPSES article.
The Latest on: Heart failure
via Google News
The Latest on: Heart failure
- FDA Approves New Form of Device Therapy for Heart Failure, the Barostim Neoon August 16, 2019 at 5:55 pm
The Barostim Neo (CVRx) implantable pulse-generator system has gained US Food and Drug Administration (FDA) approval for reduced-ejection-fraction heart failure (HF) deemed unsuitable for other device ...
- FDA approves new device to improve symptoms in patients with advanced heart failureon August 16, 2019 at 5:01 pm
SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart ...
- Last-Resort Device OK'd for Advanced Heart Failureon August 16, 2019 at 3:18 pm
WASHINGTON -- An implanted cardiac neuromodulator that provides baroreflex stimulation in patients with hard-to-treat advanced heart failure won FDA approval, the agency announced late Friday. The ...
- CVRx Receives FDA Approval for World's First Heart Failure Neuromodulation Deviceon August 16, 2019 at 1:45 pm
BAROSTIM™ NEO provides significant clinical benefit to heart failure patients MINNEAPOLIS, Aug. 16, 2019 /PRNewswire/ -- CVRx, Inc., a private medical device company, announced today that it has ...
- Heart disease and diabetes: Is dairy fat different?on August 16, 2019 at 6:38 am
Dairy foods have been getting a lot of attention from researchers in recent years, notably from studies done both jointly and separately by scientists at Harvard and Tufts universities. They ...
- Flavonoids in Foods Like Apples and Green Tea Can Protect Against Cancer, Heart Diseaseon August 15, 2019 at 2:24 pm
Share on Pinterest Experts say the anti-inflammatory properties of flavonoid-rich foods, such as apples, may help reduce the risk of cancer and heart disease. Getty Images Researchers say foods rich ...
- Miracle baby born with severe heart disease, taken off life support, about to celebrate 1st birthdayon August 15, 2019 at 10:51 am
(FOX NEWS) - A young infant born with a severe heart defect is being hailed as a miracle baby as she is set to celebrate her first birthday just months after being taken off life support with few ...
- Eating Flavonoid-Rich Foods Can Lower Your Risk of Cancer and Heart Disease—Here's What You Need to Knowon August 14, 2019 at 2:40 pm
Most people want to do their best to lower the risk of developing scary illnesses like cancer and heart disease. (If you don’t, we should talk.) While some factors like genetics can’t be helped, ...
- Philadelphia gene therapy startup targeting heart disease raises $11Mon August 14, 2019 at 8:53 am
A Philadelphia biopharmaceutical company spun out of Temple University that is developing gene therapy-based treatments for cardiovascular disease has raised $11 million in a venture capital financing ...
via Bing News